December 2006
2006 in Review, Plans for 2007
December 27, 2006
Well it's that time of year again - a chance to look back, reflect, and then clean the slate for a new calendar year. We're particularly excited about 2007 because of some major ideas we're already working on for the SmallCap Digest (though you'll have to be patient in the meantime). Yet, we'd be amiss...
Well it's that time of year again - a chance to look back, reflect, and then clean the slate for a new calendar year. We're particularly excited about 2007 because of some major ideas we're already working on for the SmallCap Digest (though you'll have to be patient in the meantime). Yet, we'd be amiss...
November 2006
Potential Opportunity in a Novel Cancer Treatment
November 21, 2006
It's always fun to present a piece of good news about one of our profiled companies. But, when we have to decide which of two pieces of good news to start with, well...let's just say we love taking on the challenge. We think either of today's tidbits could leave investors with a very positive opinion...
It's always fun to present a piece of good news about one of our profiled companies. But, when we have to decide which of two pieces of good news to start with, well...let's just say we love taking on the challenge. We think either of today's tidbits could leave investors with a very positive opinion...
October 2006
Multicell's Library of New Biopharma Ideas
October 07, 2006
Although I specifically try to avoid writing in a casual 'first person' for the SmallCap Digest, I'm willing to make an exception this time. After all, it is a weekend edition, and time to relax, right? Besides, it's much easier to make point when the barriers of journalistic stiffness are broken down...
Although I specifically try to avoid writing in a casual 'first person' for the SmallCap Digest, I'm willing to make an exception this time. After all, it is a weekend edition, and time to relax, right? Besides, it's much easier to make point when the barriers of journalistic stiffness are broken down...
September 2006
Making a Move on Multicell
September 28, 2006
In our ongoing quest to find the best undervalued small-cap stock ideas before anyone else does, we recently came across an enterprise that could fit the description very nicely...and make some money for shareholders to boot. The company's drug therapies are on the cutting-edge of an $8 billion dollar...
In our ongoing quest to find the best undervalued small-cap stock ideas before anyone else does, we recently came across an enterprise that could fit the description very nicely...and make some money for shareholders to boot. The company's drug therapies are on the cutting-edge of an $8 billion dollar...
